simendan has been researched along with ba 41899 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boknik, P; Gams, E; Herzig, JW; Neumann, J; Scholz, H; Zimmermann, N | 1 |
| Endoh, M | 1 |
1 review(s) available for simendan and ba 41899
| Article | Year |
|---|---|
Cardiac Ca2+ signaling and Ca2+ sensitizers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Azocines; Calcium; Calcium Signaling; Cardiotonic Agents; Cholinergic Agonists; Dihydropyridines; Endothelins; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Quinolines; Simendan; Thiadiazines; Troponin C | 2008 |
1 other study(ies) available for simendan and ba 41899
| Article | Year |
|---|---|
Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Topics: Azocines; Calcium; Cardiotonic Agents; Cyclic AMP; Heart; Humans; Hydrazones; In Vitro Techniques; Myocardial Contraction; Myocardial Stunning; Pyridazines; Simendan | 1998 |